2021 Global Finalists

Startups come from 80 countries for the chance to pitch at XTC. Although they have different homes and backgrounds, there is one thing in common: Their innovations could make the world a better place
Phagomed Biopharma logo

Phagomed Biopharma


Synthetic biology platform - called the LysinBuilder - that uses prediction algorithms to design novel precision antibiotics in weeks instead of years. PhagoMed's lead program PM-477 is a synthetic lysin for the treatment of antibiotic-resistant Bacterial Vaginosis, which affects 100 million women globally. PM-477 kills only the bad bacteria without harming the good vaginal bacteria. Following this success, the company is now rolling out the LysinBuilder to other pathogens.

Connect with the Phagomed Biopharma team